Page last updated: 2024-10-31

neostigmine and Jaundice

neostigmine has been researched along with Jaundice in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DIMENSHTEIN, IB1

Other Studies

1 other study available for neostigmine and Jaundice

ArticleYear
[CLINICAL IMPORTANCE OF THE PROSERIN TEST IN CHRONIC PANCREATITIS, CHRONIC CHOLECYSTITIS AND OBSTRUCTIVE JAUNDICE].
    Terapevticheskii arkhiv, 1965, Volume: 37

    Topics: Cholecystitis; Humans; Jaundice; Jaundice, Obstructive; Neostigmine; Pancreatitis; Pancreatitis, Chr

1965